NAPA Reauthorization Act

The NAPA Reauthorization Act (S 133) extends the National Alzheimer’s Project through 2035, replacing previous 2025 deadlines. It requires annual progress evaluations on research, risk reduction, and health equity, with new provisions to promote healthy aging, address Alzheimer’s risk factors, and expand focus to underserved groups - including people with Down syndrome and historically high-risk populations. The bill mandates updated advisory committee membership, including individuals with Alzheimer’s diagnoses and representatives from underserved communities. These changes directly affect federal health agencies, researchers, and healthcare planning efforts focused on Alzheimer’s prevention and care.